Efficacy of argon plasma coagulation for gastric antral vascular ectasia associated with chronic liver disease

Sato, Takahiro; Yamazaki, Katsu; Toyota, Jouji; Karino, Yoshiyasu; Ohmura, Takumi; Akaike, Jun; Kuwata, Yasuaki; Suga, Toshihiro

doi:10.1016/j.hepres.2005.04.004

Cited by 29 publications

(17 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Severe complications are infrequent and mainly represented by immediate or post-procedure bleeding [14, 21] or, rarely, septicaemia [14]. However, few data on the efficacy and safety of APC treatment in patients with liver cirrhosis are available [12, 22], especially in patients with Child C cirrhosis.…”

Section: Discussionmentioning

confidence: 99%

Endoscopic Argon Plasma Coagulation for the Treatment of Gastric Antral Vascular Ectasia-Related Bleeding in Patients with Liver Cirrhosis

et al. 2009

View full text Add to dashboard Cite

Background and Aim: Gastric antral vascular ectasia (GAVE) is a cause of bleeding in patients with liver cirrhosis. Argon plasma coagulation (APC) is the most used endoscopic treatment for GAVE-related bleeding. Treatment failures have been described in patients with haemorrhagic diathesis; post-procedure complications include haemorrhages and septicaemia. The aim of the study was to evaluate efficacy and safety of APC treatment of GAVE-related bleeding in patients with liver cirrhosis. Methods: Patients included were suffering from GAVE-related bleeding and liver cirrhosis. APC treatment was performed until eradication. Resolution of transfusion-dependent anaemia and evaluation of complications were the primary outcomes. Results: 20 patients (16 Child C and 4 Child B) were enrolled and prospectively followed for a mean period of 28 months. GAVE eradication was achieved in all patients after a median of 3 sessions (range 1–10). Resolution of anaemia was achieved in 18 patients. Six patients had relapse of GAVE after a mean of 7.7 months, successfully retreated by APC. Hyperplastic polyps developed in 3 patients causing active bleeding in 2 cases. Five patients had liver transplants and 1 had a relapse of GAVE after transplantation. Conclusion: APC is an effective and safe endoscopic treatment for GAVE in patients with liver cirrhosis.

show abstract

Section: Discussionmentioning

confidence: 99%

Endoscopic Argon Plasma Coagulation for the Treatment of Gastric Antral Vascular Ectasia-Related Bleeding in Patients with Liver Cirrhosis

et al. 2009

View full text Add to dashboard Cite

show abstract

“…Several studies have demonstrated the beneficial effect of this method in patients with GAVE 46, 58, 60, 72-78. The main advantage of argon-plasma coagulation is that it is easy to use and the risk of perforation is lower than with Nd:YAG laser.…”

Section: Gastric Antral Vascular Ectasiamentioning

confidence: 99%

Management of Gastropathy and Gastric Vascular Ectasia in Portal Hypertension

Ripoll

García–Tsao

2010

Clinics in Liver Disease

View full text Add to dashboard Cite

“…The combination of a superficial depth of penetration and the non-contact mode of application are ideal for the treatment of mucosal lesions of the gastrointestinal (GI) tract [8].…”

Section: Discussionmentioning

confidence: 99%

“…Argon plasma coagulation and electrocautery have both been used to stop bleeding from ectatic vessels, and to attempt to obliterate the vessels, but have limited utility if the disease is diffuse [8].…”

Section: Introductionmentioning

confidence: 99%

Effect of Endoscopic Argon Plasma Coagulation on Gastrointestinal Blood Loss Due to Portal Hypertensive Gastropathy

Hashim¹,

Zaky²,

Berengy³

et al. 2017

J Clin Gastroenterol Hepatol

View full text Add to dashboard Cite

Background: Portal hypertensive gastropathy (PHG) is one of the clinical conditions that can cause chronic gastrointestinal hemorrhage in patients with cirrhosis, manifested by chronic anemia. It is generally diagnosed on the basis of endoscopic features. A new thermal modality has recently been introduced to endoscopy: the argon plasma coagulator (APC). Hemostasis is a main target for the use of APC and its role in ceasing PHG related acute and chronic bleeding is being efficient and safe when studied in the past few years.

show abstract

Efficacy of argon plasma coagulation for gastric antral vascular ectasia associated with chronic liver disease

Cited by 29 publications

References 25 publications

Endoscopic Argon Plasma Coagulation for the Treatment of Gastric Antral Vascular Ectasia-Related Bleeding in Patients with Liver Cirrhosis

Endoscopic Argon Plasma Coagulation for the Treatment of Gastric Antral Vascular Ectasia-Related Bleeding in Patients with Liver Cirrhosis

Management of Gastropathy and Gastric Vascular Ectasia in Portal Hypertension

Effect of Endoscopic Argon Plasma Coagulation on Gastrointestinal Blood Loss Due to Portal Hypertensive Gastropathy

Contact Info

Product

Resources

About